Pro51 Cost-effectiveness and Budget Impact of Onasemnogene Abeparvovec for Spinal Muscular Atrophy Type 1: Post-hoc Analysis of a Model Developed by Icer
Year: 2019
Type: conference-abstract
Source: Value in Health
Institution: University of Arizona
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2996416411